Seragon Pharmaceuticals

Develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer.

HQ location

Irvine, United States

Website

seragonpharm.com

Launch date

2013

Employees

Enterprise value

$120—180m

https://twitter.com/genentech https://www.facebook.com/pages/Seragon-Pharmaceuticals/533884266684113 https://www.linkedin.com/company/seragon/

Authorizing premium user...